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NMRThe human cluster determinant 4 (CD4) is a type I transmembrane glycoprotein involved in T-cell signalling.
It is expressed primarily on the surface of T helper cells but also on subsets of memory and regulatory T
lymphocytes (CD4+ cells). It serves as a coreceptor in T-cell receptor recognition of MHC II antigen
complexes. Besides its cellular functions, CD4 serves as the main receptor for human immunodeﬁciency virus
type I (HIV-1). During T-cell infection, the CD4 extracellular domain is bound by HIV-1 gp120, the viral
surface glycoprotein, which triggers a number of conformational changes ultimately resulting in virion entry
of the cell. Subsequently, CD4 is downregulated in infected cells by multiple strategies that involve direct
interactions of the HIV-1 proteins VpU and Nef with the cytoplasmic part of CD4. In the present work, we
describe the NOE-based solution structure of the transmembrane and cytoplasmic domains of the cystein-
free variant of CD4 (CD4mut) in dodecylphosphocholine (DPC) micelles. Furthermore, we have characterized
micelle-inserted CD4mut by paramagentic relaxation enhancement (PRE) agents and 1H-15N heteronuclear
NOE data. CD4mut features a stable and well-deﬁned transmembrane helix from M372 to V395 buried in the
micellar core and a cytoplasmic helix ranging from A404 to L413. Experimental data suggest the amphipathic
cytoplasmic helix to be in close contact with the micellar surface. The role of the amphipathic helix and its
interaction with the micellar surface is discussed with respect to the biological function of the full-length
CD4 protein.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Still, membrane proteins represent very challenging objects for
high-resolution structure determinations. In the current study, we use
liquid-state nuclear magnetic resonance (NMR) spectroscopy to
investigate the 3D structure of a micelle-inserted transmembrane
protein combined with dynamical data. High-resolution NMR
approaches provide diverse data on integral membrane proteins
(IMPs). The chemical shift values are sensitive to backbone torsion
angles [1] and can be used for identiﬁcation of secondary structure
elements. NOESY spectra contain information on proton–proton
distances and yield input for restrained molecular dynamics-based
structure calculation [2]. Conﬁnement of micelle- or bicelle-incorpo-
rated IMP in an asymmetric environment, e.g., a stressed polyacryl-
amide gel [3,4], allows measurement of residual dipolar couplings,
which are sensitive to bond vector orientation to assist thedodecylphosphocholine; ER,
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ll rights reserved.determination of the 3D structure of the protein backbone [5]. The
location and topology of the helices are derived from periodic patterns
in the dipolar couplings [6]. High-resolution NMR measurements of
relaxation times and 1H-15N heteronuclear NOEs give detailed insight
into local backbone dynamics [7,8]. Protein–protein interactions can
be addressed by liquid-state NMR. A variety of approaches has been
used for detection of binding, for mapping of the binding site onto the
surface of the interaction partners, and even in-depth characterization
of the complex structure [9,10].
Reconstitution of membrane proteins in a suitable environment
has always been a ﬁeld of very broad interest. Not only for structural
studies, IMPs have to be properly folded upon reinsertion to maintain
biological functionality. This requires the choice of suitable lipids or
lipid mixtures for IMP embedding. In addition, the overall mass of the
IMP-bearing particle must be small enough to ensure short rotational
correlation times, if liquid-state NMRmethods ought to be used. Then
even small liposomes are too large in molecular weight. Instead,
numerous membrane-mimicking conditions have been explored to
allow solubilization of the IMP while closely matching the physico-
chemical environment of the membrane and, at the same time, being
suitable for liquid-state NMR. Reviews on the available options for
membrane protein solubilization [11–13] and evaluations of a
multitude of detergents for solution NMR studies on IMPs [14, 15]
have been published. Detergent micelles have been used to study
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spanning helices [17], as well as β-barrel proteins [18].
In the present study, we gathered detailed structural and dynamic
information of the human cluster determinant 4 (CD4) protein. CD4 is
a 433-residue type I transmembrane glycoprotein involved in T-cell
signalling of MHC-II-restricted T lymphocytes [19]. The function of
these CD4+ T-cells relies on the direct interaction between CD4 and
the major histocompatibility complex type II (MHC-II) presenting an
antigen on the surface of a macrophage [20]. The extracelluar segment
of CD4, consisting of 371 amino acid residues, contains four
immunoglobulin-like domains [21]. This ectodomain participates in
a complex with the antigen-speciﬁc T-cell receptor (TCR) and serves
as coreceptor that binds to the non-polymorphic region of MHC-II.
In addition to its cellular functions, CD4 is the major receptor for
human immunodeﬁciency virus type I (HIV-1) [22,23]. Thus, CD4 is
targeted by several HIV-1-coded proteins. HIV-1 negative factor (Nef)
binds directly to the cytoplasmic part of CD4 and downregulates CD4
from the cell surface [24,25]. HIV-1 viral protein U (VpU) also binds
directly to CD4 cytoplasmic domain to prevent further delivery of
newly synthesized CD4 from the ER to the cell surface by inducing
CD4 degradation via the ubiquitin-dependent proteasomal pathway
[26,27]. The CD4 sequence region responsible for this function is
located between amino acid residues 402 to 420 [28]. From
mutational analysis, it is known that residues 407 to 418 in the
cytoplasmic domain of CD4 are necessary and sufﬁcient for down-
regulation of CD4 by Nef [24,25,29]. The di-leucine motif at sequence
positions 413 and 414 of CD4 plays a crucial role in Nef binding [30].
Previously, we employed secondary chemical shift analysis for
identiﬁcation of secondary structure elements within residues 372 to
433 of CD4mut, which resembles the transmembrane and cytoplasmic
domains of CD4 with its ﬁve cysteines being conservatively replaced
by four serines and one histidine [31]. Two helices were found ranging
from amino acid residue 372 to 395 and from residue 407 to 412,
reﬂecting the transmembrane and cytoplasmic helices of CD4,
respectively [32]. The aim of the current study is characterization of
the 3D structure of CD4mut based on proton–proton distance
constraints from nuclear Overhauser enhancement (NOE) data. In
addition, information on CD4mut has been collected based on
heteronuclear 1H-15N-NOE data, water protection factors, and
enhancement of spin relaxation by paramagnetic probes.
2. Materials and methods
Perdeuterated dodecylphosphocholine (DPC-d38), 2H2O, [U-13C]
glucose and [U-15N] ammonium chloride were purchased from
Cambridge Isotope Laboratories. HPLC grade organic solvents were
used. All other chemicals were graded analytical or better.
2.1. Expression and puriﬁcation of CD4mut
CD4mut covers residues 372 to 433 of human CD4 comprising the
transmembrane and cytoplasmic domains with ﬁve cysteines being
conservatively replaced by four serines and one histidine [31].
CD4mut was expressed in Escherichia coli as a fusion protein
containing an N-terminal His-tag, ubiquitin, and a short linker
containing protease cleavage sites. After enzymatic cleavage of the
fusion protein with PreScission protease, the eight amino acid
residues GPLVPRGS remain at the aminoterminal end of CD4mut:
MAL IVLGGVAGLLLF IGLG IFFSVRSRHRRRQAERMSQIKRLL -
SEKKTSQSPHRFQKTHSPIwith all residues given in the one-letter code.
The puriﬁcation of CD4mut comprises detergent-based cell lysis,
metal afﬁnity puriﬁcation of the fusion protein, a desalting step,
PreScission cleavage, TCA precipitation, and reversed phase chroma-
tography. About 8 mg of uniformly 13C, 15 N-labeled CD4mut was
regularly obtained per liter of isotope-labeled M9 minimal medium.Details on cloning, expression, and puriﬁcation of CD4mut have been
published [31,32].
2.2. NMR sample preparation
The NMR sample contained 1 mM of CD4mut in 90% H2O/10 %
2H2O micellar solution (200 mM DPC-d38, 20 mM sodium phosphate,
150mMNaCl, 0.02% (w/v) NaN3, pH 6.2). The sample was transferred
to a (3×6) mm2 2H2O-matched Shigemi S-tube (Varian Inc., Palo Alto,
USA) or 5 mm Shigemi tube after adjusting the pH to 6.2. Some
experiments were conducted in 2H2O after lyophilizing and redissol-
ving the sample in 99.996% 2H2O. Additional experiments were
carried out with CD4mut in SDS micelles (200 mM SDS, 20 mM
sodium phosphate, 150 mM NaCl, 0.02% (w/v) NaN3, pH 6.5).
2.3. Data acquisition and processing
NMR spectra for sequential resonance assignment were acquired
at 14.1 T, while NOESY spectra for obtaining distance constraints were
acquired at 14.1 T and 18.8 T. Experiments were conducted at 45 °C on
Varian Unity INOVA spectrometers using cryogenically cooled 5 mm
Z-PFG-1H{13C, 15N} probes.
The resonance assignment strategy has been described earlier [32].
Shortly, a set of standard 2D and 3D spectra based on a transverse
relaxation-optimized (TROSY) [33] variant of the 1H, 15N-HSQC [34]
was recorded for backbone assignment, while 2D and 3D 1H, 13C-
HSQC-based [35] spectra were acquired for the side chain assignment.
Proton–proton distances were extracted from gradient-enhanced 3D
15N-NOESY-HSQC spectra [36] acquired with a mixing time of 150 ms,
and from 3D gradient-enhanced 13C-resolved HSQC-NOESY spectra
[37] recordedwith amixing time of 120ms. Data were processed with
NMRPipe [38] and VNMRJ (Varian Inc.) and CARA was used for
spectral analysis and resonance assignment [39].
2.4. NOE assignment and structure calculation
Interproton distances were derived from NOESY data using
RADAR, an automated NOESY spectral analysis software. RADAR
combines ATNOS [40] for automated NOESY peak picking and NOE
signal identiﬁcation in NOESY spectra, CANDID [41] for combined
automated NOE assignment and structure calculation, and the torsion
angle dynamics-based simulation algorithm CYANA [42]. RADAR runs
an iterative process consisting of seven cycles. Within a cycle, ATNOS
performs a baseline correction and signal-to-noise estimation, as well
as identiﬁcation of potential NOE signals in concordance with the
user-provided chemical shift assignment table. CANDID uses the
chemical shift table and the presence of symmetrical cross-correla-
tions, as well as the compatibility with the polypeptide chain for
assignment of NOE correlations. The subsequent integration and
calibration of the signals result in a list of upper distance constraints
[42] without artefacts and ambiguous constraints. The set of upper
distance constraints serves as input for torsion angle dynamics with
CYANA. The resulting structure ensemble is utilized for identiﬁcation
and assignment of NOE resonances in the next cycle of RADAR.
After the last automatic iteration step, the set of upper distance
constraints was further examined manually in an interactive and
iterative process. CYANA was used to calculate 100 structures based
on the NOE data. The ensemble of the 20 least energy conformers was
deposited in the Protein Data Bank (PDB) under accession code 2klu.
MOLMOL [43] was used for visualization and analysis of the structural
ensemble.
2.5. Determination of hetero-NOEs
Heteronuclear 1H-15N NOEs were derived from 2D spectra
acquired at 18.8 T using a TROSY-based [33] NOE pulse sequence
Table 1
Summary of structural statistics of CD4mut in DPC micelles.
Experimental restraints
Total NOE restraints 623
Intraresidue 231
Sequential 214
Medium range (2≤ |i− j|≤5) 178
CYANA structural statistics
Target function 0.017±0.008 nm2
Sum of NOE violations N0.015 nm 0.13 nm
Maximum violation 0.03 nm
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saturation with a series of 120° pulses spaced at 5-ms intervals prior
to the ﬁrst pulse of the NOE sequence, respectively. NOE intensities
were obtained by ﬁtting these peaks to an adjustable “model peak”
shape in CARA [39]. A superposition of Gauss and Lorentz functions
was employed, where Gauss-Lorentz balance and linewidth can easily
be adjusted manually and independently for both spectral dimen-
sions. Finally, a complete list of 1H-15N-NOE intensities was obtained
for both spectra, and the heteronuclear NOE was derived as the ratio

















2.6. Determination of water protection factors
Labile amide protons easily exchange with protons of the water.
Engagement of these protons in hydrogen bonds of regular secondary
structure elements such as alpha helices or beta sheets results in
protection from exchange and thus in a longer “lifetime” of the
respective amide proton signals.
Amide cross peak intensities were derived from 1H, 15N-TROSY-
HSQC spectra. First, an HSQC spectrum of CD4mut in DPCmicelles was
recorded in buffer containing 90% H2O/10% 2H2O. Subsequently, the
sample was lyophilized and redissolved in 100% 2H2O. HSQC spectra
were recorded immediately after reinsertion of the sample into the
magnet, and after 1, 2, and 4 h.
2.7. DPC micelle interaction of CD4mut
The position of CD4mut with respect to the micelle was studied
using the paramagnetic relaxation agents 16- and 5-doxylstearic acid,
respectively. Paramagnetic relaxation enhancement (PRE) causes
broadening of protein NMR signals in the vicinity of the probe. The
PRE is quantiﬁed in terms of signal retention in HSQC spectra recorded
with and without the paramagnetic agent in the sample, respectively
[45]. In initial experiments, we tested a range of concentration
between 0.2 and 8 mM for both agents. The ﬁnal data were recorded
with a molecular ratio between paramagnetic relaxation agents and
protein of 5:1.
3. Results and discussion
3.1. Secondary structure of CD4mut determined by
NOE-derived constraints
Nearly complete resonance assignment of DPC micelle-inserted
CD4mut has been reported earlier [32]. Secondary chemical shift
analysis predicted a transmembrane α-helix from 372 to 395 and a
short α-helix from residue 407 to 412.
To verify the existence of the predicted secondary structure
elements and to obtain potential tertiary structural data, NOE data
have been collected of CD4mut in DPC micelles in the present study.
For the structure calculations, a total of 623 NOE distance constraints
have been used. Another 233 dihedral constraints were derived from
chemical shift data using the program TALOS [46], which is
implemented in the RADAR routine, and included in the calculation
of the ﬁnal structure. A ﬁnal ensemble of 20 NMR structures with the
lowest CYANA target functions were used to characterize thestructure of CD4mut in DPC micelles. None of the 20 structures
violated NOE distances by more than 0.030 nm. No dihedral-angle
constraint was violated more than 5°. A summary of the experimental
constraints and structural statistics is given in Table 1. Long-range
NOE contacts could not be observed. Therefore, the overall structure
ensemble does not converge to a unique conformer. However, well-
deﬁned secondary structure elements were obtained from the
structure calculations.
The transmembrane helix comprising residues M372 to V395 is
reasonably well deﬁned with an average root-mean-squared devia-
tion (RMSD) of 0.3 nm for the backbone atoms (Fig. 1). Notably, the
side chain of F392 strongly points towards the C-terminus of the helix,
while usually side chains of residues involved in helical structures
point towards the amino-terminus (Fig. 1). The alignment between
the voluminous side chains of F392, F393 and R396 is well deﬁned by
direct NOE correlations. In particular, the NOE correlations giving rise
to this structural feature are F392-CHα − V395-CHβ, F392-CHα −
V395-CH3γ, F392-CH2δ − R396-CH2δ, F392-CH2ɛ − R396-CH2δ, F393-CHα
− R396-CH2β, F393-CHα − R396-CH2γ, and F393-CH2δ − R396-CH2δ.
The tilt of the long axis of a transmembrane helix with respect to
the membrane normal might play an important role for membrane
protein function and molecular interactions. Unfortunately, solution
NMR on integral membrane proteins in a micellar environment
cannot answer this question. In the future, however, we plan to
complement our results with solid-state NMR data obtained on CD4 in
liposomes. Combination of experimental restraints from solution and
solid-state NMR data with molecular dynamics simulation might very
well allow a more detailed understanding of CD4 structure and
interactions [47].
A second helix ranging from residue A404 to L413 is deﬁnedwith an
RMSD value of 0.6 nm in the cytoplasmic part of the molecule (Fig. 2).
Although in theﬁnally obtained structure ensemble the typicalα-helical
hydrogen bonding pattern is present only for residues M407 to R412,
helical conformation together with a decreased RMSD value is observed
for residues A404 to L413 (Fig. 2). Because of the absence of long-range
NOEs between residues of this helix and those of the transmembrane
helix, the relative orientation between both helices is not deﬁned.
The structure of the cytoplasmic domain has been subject to earlier
investigations by NMR and CD spectroscopy using the soluble
synthetic peptides CD4(403–419) [48] and CD4(396–433) [49,50].
Willbold and Rösch identiﬁed an α-helix in aqueous solution ranging
fromQ403 to R412.Wray et al. studied the cytoplasmic domain of CD4
in water and triﬂuoroethanol (TFE) solution. In aqueous solution, the
peptide was reported to be unstructured [49,50], while helical
conformation was adopted in presence of buffer containing TFE. In
presence of 50 vol.% TFE, an α-helix is induced containing residues
R402 to K417 [50]. In sum, the cytoplasmic helix derived in the
present study is in reasonable agreement with previous studies.
Fig. 1. Structure of the transmembrane helix of CD4mut calculated from NOE-derived upper distance constraints. (A) Ensemble of the 20 lowest energy conformers from torsion
angle dynamics. Superposition is based on minimization of the RMSD between all backbone heavy atoms of M372 to V395 with respect to the lowest energy conformer. (B) Ribbon
representation of one representative conformer of the transmembrane helix of CD4mut. Bonds between heavy atoms in the side chains are shown by sticks. (C) C-terminal end of the
transmembrane helix. Side chains of F392, F393, and R396 are marked.
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local backbone dynamics on the pico- to nanosecond time scale [7].
Positive 1H-15N NOEs close to the value of 0.8 indicate the respective
residue to be contained in a rigid structure. Thus, a rigid structure can
be inferred for most of the transmembrane residues. The residues
forming the cytoplasmic helix and the interhelical region show
heteronuclear NOE values around 0.5, which indicates only a small
degree of ﬂexibility, even at 45 °C. Rapid internal motion will reduce
the heteronuclear NOE, which may even become negative for highly
mobile residues exhibiting large amplitude motions on the sub-
nanosecond time scale [51]. Such a behaviour is observed towards the
C-terminal end of the CD4mut protein. The respective heteronuclear
NOE values demonstrate this region to be highly ﬂexible (Fig. 3).
3.2. Structure of the inter-helix region
The structure of CD4mut is dominated by two helical segments
M372 to V395 and A404 to L413. The NOE pattern of the interhelical
region does not indicate any regular secondary structure elements.
The average hetero-NOE in this region is reduced and amounts to
∼0.3. Apparently, the interhelical linker exhibits some structural
ﬂexibility but it is not completely mobile. The short interhelical region
R396-SRHRRR-Q403 is located at the polar lipid–water interface.
Thus, it is in contact with the zwitterionic DPC head groups and water
molecules. The interhelical region contains a dense cluster of positive
charges. This high net charge might prevent secondary structure
formation. The situation might be quite different at the negatively
charged surface of the ER membrane. Therefore, we also studied
CD4mut inserted in negatively charged sodium dodecyl sulfate (SDS)
micelles. In particular, we analyzed secondary chemical shifts of
CD4mut residues located in the two helices and the interhelical linker.Fig. 2. Structure of the cytoplasmic helix from torsion angle dynamics. (A) Twenty
lowest energy conformers are shown. Superposition is based on all backbone heavy
atoms of A404 to L414. (B) Ribbon representation of one representative conformer. Side
chain bonds are shown as sticks. The conformer is in the same orientation as the bundle
in panel (A).The pattern of secondary chemical shifts of CD4mut in SDS is very
similar to the pattern observed in DPC (data not shown). The only
notable difference is an extension of the transmembrane helix by two
residues (396 and 397). However, no indications for helical structure
of the remaining residues 398 to 403 of the linker were found neither
in DPC nor SDS.We conclude that the interhelical region remains non-
helical independent of the presence of negatively charged lipids.3.3. CD4mut interaction with the micelle
To probe the interaction of CD4mut with DPC micelles, we used
16- and 5-doxyl stearic acid to map residues that are deeply buriedFig. 3. 1H -15N-hetero-NOE values and amide proton exchange times of CD4mut in DPC
micelles. (A) 1H-15N-hetero-NOE values of backbone amides of CD4mut in DPC
micelles. Intensities of residues marked with an asterisk (⁎) could not be derived due to
heavy spectral overlap. Proline residue positions are marked with a plus (+). (B)
Exchange times of amide protons of CD4mut in DPC micelles. Intensities of residues
marked with an asterisk (⁎) could not be derived due to heavy spectral overlap. Proline
residue positions are marked with a plus (+).
126 M. Wittlich et al. / Biochimica et Biophysica Acta 1798 (2010) 122–127in the micelle or closer to the micelle surface, respectively [45]. It
can be expected that 16-doxyl stearic acid causes a reduction in the
resonance intensities of amino acids located nearby the micellar
core. 5-Doxyl stearic acid, however, will also cause resonance
intensity reduction of residues near the micellar core, but residues
closer to the micelle surface are expected to be even more affected.
Fig. 4 summarizes the results. Residues 380 to 390 are most
affected by 16-doxyl stearic acid, while intensity retention becomes
smaller towards the ends of the micelle spanning helix (Fig. 4A).
Unexpectedly, residues from R369 towards the N-terminus of the
protein experienced intensity retention. Possibly, because of the
elongated chain length of 16-doxyl stearic acid in comparison to
the hydrophobic part of DPC, a fraction of 16-doxyl stearic acid
molecules are oriented unexpectedly. This may also explain why
virtually all residues of CD4mut, except the very C-terminal
residues, are affected by an overall reduction of their signal
intensities. The pattern of residues affected by 5-doxyl stearic
acid is exactly as expected. Residues 380 to 390 in the center of the
micelle are hardly affected, but residues around 370 and 399, which
are expected to be close to the micelle water interface, are
signiﬁcantly affected. Remarkably, there is an interesting periodicity
of the resonance intensity reductions for residues of the cytoplas-
mic helix A404 to L413 (404, 407, 409, 410, 413), which is in
agreement with close proximity of this α-helix to the micellar
surface (Fig. 4B). The C-terminal region of the protein is virtually
unaffected by the paramagnetic agents. The signal intensityFig. 4. Paramagnetic relaxation enhancement obtained for CD4mut in DPC micelles
using 16- and 5-doxylstearic acid. Intensity retention is plotted as a function of amino
acid sequence position. (A) Intensity retention plot for CD4mut in the presence of 5mM
16-doxylstearic acid (5:1 relaxation agent/protein molar ratio). (B) Intensity retention
plot for CD4mut in the presence of 5 mM 5-doxylstearic acid (5:1 relaxation agent/
protein molar ratio).reductions induced by 16-doxyl stearic acid have been mapped
onto the surface of a low-energy CD4mut conformation (Fig. 5A).
For comparison, the surface electrostatic potential map of CD4mut
is illustrated in Fig. 5B.
3.4. H/D exchange experiments
The stability of hydrogen bonds of CD4mut in DPC micelles was
assayed by H/D exchange experiments. Labile hydrogens rapidly
exchange with solvent atoms. After transferring a protein from H2O to
2H2O, such protons rapidly exchange for deuterons, that is, they
become invisible in 1H, 15N-HSQC spectra. Protons involved in stable
hydrogen bonds are partially protected from exchange and may be
detected in the spectra for a prolonged period after solvent exchange.
HSQC signal intensity wasmeasured as a function of time after solvent
exchange and is presented as a function of residue number in Fig. 3B.
The plot clearly shows two regions with reduced hydrogen exchange
rates. Backbone amide protons of the transmembrane helix are
observable for several hours after solvent exchange. Residues in the
center of the amphipathic helix withstand exchange for about an
hour. These observations are in agreement with the proposed burial of
the transmembrane helix in the hydrophobic interior of the micelle
and a location of the cytoplasmic helix at the micelle water interface
[52].
In summary, the structure of the transmembrane and cytoplasmic
domains of CD4 can be described by a very stable and rigid
transmembrane α-helix (372–395) and a second cytoplasmic α-
helix (403–413), which is reasonably stable even at 45 °C supported
by helix-type NOE patterns, H/D exchange experiments, and hetero-
nuclear NOE values. Obviously, the amphipathic character of the helix
tethers the structure to the micellar surface. Notably, the region in
HIV-1 VpU, which is responsible for CD4 binding, also features a long
amphipathic helix [53,54]. Conﬁning the two amphipathic helices to
the polar membrane interface might be crucial for productiveFig. 5. Surface representation of paramagnetic quenching and electrostatic potential for
CD4mut residues. (A) The degree of NMR signal quenching is indicated by different
shades of green colour. Dark green indicates maximum quenching, while light green
symbolizes intermediate effects. White is used to indicate absence of quenching. Amino
acid residues that could not be evaluated are coloured in magenta. (B) Electrostatic
potential plot of CD4mut shows a high concentration of positively charged residues
(blue) in the interhelical region.
127M. Wittlich et al. / Biochimica et Biophysica Acta 1798 (2010) 122–127interaction between VpU and CD4. The very C-terminal part of CD4
(414–433) is largely unstructured.
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